GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Total Long-Term Liabilities

Ectin Research AB (XSAT:ECTIN B) Total Long-Term Liabilities : kr0.73 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Ectin Research AB's Total Long-Term Liabilities for the quarter that ended in Mar. 2024 was kr0.73 Mil.

Ectin Research AB Total Long-Term Liabilities Historical Data

The historical data trend for Ectin Research AB's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Total Long-Term Liabilities Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
Total Long-Term Liabilities
0.73 0.73 0.73 0.73

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.73 0.73 0.73 0.73

Ectin Research AB Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Ectin Research AB Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ectin Research AB (XSAT:ECTIN B) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Total Long-Term Liabilities
Comparable Companies
OSTO:QUIA XSAT:EUCI OSTO:LIDDS OSTO:PROMO OSTO:CLINE B OSTO:AMNI OSTO:REDW XSAT:ALTE OSTO:PHARM OSTO:DIABIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Website
https://www.ectinresearch.com
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines